Abingworth as of Sept. 30, 2014
Portfolio Holdings for Abingworth
Abingworth holds 13 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prosensa Hldgs B V Shs Usd | 31.3 | $52M | 6.2M | 8.43 | |
| Lombard Med (EVARF) | 15.3 | $26M | 3.4M | 7.65 | |
| Supernus Pharmaceuticals (SUPN) | 15.0 | $25M | 2.9M | 8.69 | |
| Portola Pharmaceuticals | 14.1 | $24M | 931k | 25.28 | |
| Dicerna Pharmaceuticals | 9.0 | $15M | 1.2M | 12.72 | |
| Amarin Corporation (AMRN) | 5.3 | $8.8M | 8.1M | 1.09 | |
| Cempra | 4.7 | $7.8M | 714k | 10.96 | |
| Zogenix | 1.6 | $2.7M | 2.3M | 1.15 | |
| Regulus Therapeutics | 1.3 | $2.2M | 327k | 6.85 | |
| OncoGenex Pharmaceuticals | 1.0 | $1.6M | 604k | 2.65 | |
| Hyperion Therapeutics | 0.9 | $1.6M | 63k | 25.22 | |
| Anthera Pharmaceutcls | 0.5 | $832k | 438k | 1.90 | |
| Epirus Biopharmaceuticals In (EPRSQ) | 0.0 | $56k | 7.9k | 7.09 |
